Advancing Precision Care and Shared Decision-making in 1L HER2-Positive mBC Management: Expert Insights, Patient Resources, and Adaptive Decision Support

Learn about the latest clinical trial evidence for treating patients with HER2-positive metastatic breast cancer using antibody–drug conjugates in the earlier-line setting and learn how to engage in smart patient-oriented conversations regarding the use of novel treatments, managing adverse effects, and treatment adherence with downloadable resources; an on-demand webcast with accompanying slides; podcasts; an expert-authored clinical commentary; patient case vignettes; and an interactive decision support tool to support your practice.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC. in collaboration with Smart Patients.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Smart Patients

ProCE Banner